retatrutide clinical development Eli Lilly's New Weight-Loss Treatment Shows Promising Results!! Retatrutide, designed to be taken once a week, met the primary endpoint in a phase 3 clinical. The initial TRIUMPH Phase 3 Retatrutide Dosing Schedule: Proven 2026

This also makes it easier to hit daily protein goals incrementally

Measure waist circumference, hip circumference, and if possible body fat percentage at regular intervals

To note, with the G-agonists, GIP receptors in the brain may respond differently than those peripherally, with less GI side effects

Ahmann AJ, Capehorn M, Charpentier G et al (2018) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial

Hims does offer anti-nausea meds to eligible patients, so either he did not get them or they did not do the job

But you shouldnt eliminate them from your diet to maintain weight loss